share_log

IO Biotech Ended 2022 With ~$142.7M In Cash And Cash, Anticipates This Will Be Sufficient To Fund Operations Into Mid-2024

IO Biotech Ended 2022 With ~$142.7M In Cash And Cash, Anticipates This Will Be Sufficient To Fund Operations Into Mid-2024

IO 生物技術於 2022 年結束,現金和現金總額達 142.7 萬美元,預計這將足以為 2024 年中期的運營提供資金
Benzinga Real-time News ·  2023/01/09 07:22

IO Biotech Ended 2022 With ~$142.7M In Cash And Cash, Anticipates This Will Be Sufficient To Fund Operations Into Mid-2024

IO 生物技術於 2022 年結束,現金和現金總額達 142.7 萬美元,預計這將足以為 2024 年中期的運營提供資金

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論